Zepbound Data as Reported by Lilly The manufacturers language on the weight loss indication reads thus: Zepbound is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. At 72 weeks, patients taking Zepbound 15mg lost an average of 20.9% of their body weight
Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models
By addressing weight as part of a broader health picture, this approach can support both cosmetic and medical goals
Neuropsychopharmacology 41 , 297319 (2016)
Chris Aiken, MD Director, Psych Partners Editor in Chief, Carlat Psychiatry Report
Doses will range from 0.25 mg to 1 mg, and the starting price for a 0.25 mg pen containing 4 doses will be $24.35 (8,800 rupees)